Site icon OncologyTube

Does the UK need a National Optimal Lung Cancer Pathway?

Long waits for and between treatments, leading to worse outcomes for patients, are unacceptable. Improved care pathways are required to streamline the treatment journey. In this interview, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses the new National Optimal Lung Cancer Pathway (NOLCP). This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.

Exit mobile version